GARDASIL 9

INJ SUS 1X0,5ML

SÚKL code 0210635
Name of the product GARDASIL 9
_MA_MEDICATION_DETAIL_INFO_MED_NAME i GARDASIL 9
Supplement INJ SUS 1X0,5ML
Strenght
Pharmaceutical form Suspension for injection
Package 1X0,5ML
Route Intramuscular use
Wrap type Vial
Legal status na lékařský předpis
Active substance HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 6 PROTEINUM L1)
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 11 PROTEINUM L1)
HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 16 PROTEINUM L1)
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 18 PROTEINUM L1)
HUMAN PAPILLOMA VIRUS TYPE 31 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 31 PROTEINUM L1)
HUMAN PAPILLOMA VIRUS TYPE 33 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 33 PROTEINUM L1)
HUMAN PAPILLOMA VIRUS TYPE 45 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 45 PROTEINUM L1)
HUMAN PAPILLOMA VIRUS TYPE 52 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 52 PROTEINUM L1)
HUMAN PAPILLOMA VIRUS TYPE 58 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 58 PROTEINUM L1)
ATC group J07BM03
ATC group name PROTEIN LIDSKÉHO PAPILLOMAVIRU TYPU 6, 11, 16, 18, 31, 33, 45, 52, 58)

Marketing authorisation information

Registration Number EU/1/15/1007/001
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder MSD VACCINS, Lyon
MA Holder country FRANCIE

Back to list